GAIN THERAPEUTICS, INC Operating Leases, Future Minimum Payments, Due in Four Years
GAIN THERAPEUTICS, INC (GANX) had Operating Leases, Future Minimum Payments, Due in Four Years of $54.25 thousand as of 2022-12-31, per its 10-K filed 2023-03-23.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears · last filed 2023-03-23
- 2022-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $54.25K.
- 2022-03-31: Operating Leases, Future Minimum Payments, Due in Four Years $152.11K.
- 2021-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $167.53K.
| Period end | Operating Leases, Future Minimum Payments, Due in Four Years |
|---|---|
| 2022-12-31 | $54.25K 10-K · filed 2023-03-23 |
| 2022-03-31 | $152.11K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $167.53K 10-K · filed 2022-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B |